Any feedback?
Please rate this page
(enzyme.php)
(0/150)

BRENDA support

Disease on EC 5.4.2.4 - Bisphosphoglycerate mutase

Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
DISEASE
TITLE OF PUBLICATION
LINK TO PUBMED
Anemia
Bisphosphoglycerate Mutase Deficiency Protects against Cerebral Malaria and Severe Malaria-Induced Anemia.
Anemia, Hemolytic
[Congenital non-spherocytic hemolytic anemia by 2,3-diphosphoglycerate mutase deficiency of the erythrocytes in early infancy]
[Metabolic aspects of the erythrocytes in a case of congenital non-spherocytic hemolytic anemia with probable of 2,3-diphosphoglyceromutase deficiency]
Anemia, Refractory
[Enzyme deficiencies of blood cells in bone marrow insufficiency (author's transl]
bisphosphoglycerate mutase deficiency
Bisphosphoglycerate Mutase Deficiency Protects against Cerebral Malaria and Severe Malaria-Induced Anemia.
Compound heterozygosity in a complete erythrocyte bisphosphoglycerate mutase deficiency.
Congenital and acquired polycythemias.
Erythrocytosis due to bisphosphoglycerate mutase deficiency with concurrent glucose-6-phosphate dehydrogenase (G-6-PD) deficiency.
Glycerated hemoglobin alpha 2 beta 2(82) (EF6) N-epsilon-glyceryllysine: a new post-translational modification occurring in erythrocyte bisphosphoglyceromutase deficiency.
Glycerated hemoglobin, alpha 2A beta 2(82) (EF6) N epsilon-glyceryllysine. A new post-translational modification occurring in erythrocyte bisphosphoglyceromutase deficiency.
Hemolytic anemias and erythrocyte enzymopathies.
Red cell enzymopathies as a model of inborn errors of metabolism.
[2,3-diphosphoglycerate metabolism and 2,3-diphosphoglycerate mutase deficiency in erythrocytes]
[CONGENITAL 2,3-DIPHOSPHOGLYCEROMUTASE DEFICIENCY.]
[Congenital non-spherocytic hemolytic anemia by 2,3-diphosphoglycerate mutase deficiency of the erythrocytes in early infancy]
[Diphosphoglyceromutase deficiency: new cases associated with erythrocytosis]
[Familial diphosphoglycerate mutase deficiency: hematological and biochemical study]
[Metabolic aspects of the erythrocytes in a case of congenital non-spherocytic hemolytic anemia with probable of 2,3-diphosphoglyceromutase deficiency]
Leukemia
Induction of 2,3-bisphosphoglycerate synthase in Friend leukemia cells.
Leukemia, Erythroblastic, Acute
Molecular cloning and nucleotide sequence of murine 2,3-bisphosphoglycerate mutase cDNA.
Role and induction of 2,3-bisphosphoglycerate synthase.
Malaria
The use of enzymopathic human red cells in the study of malarial parasite glucose metabolism.
Malaria, Cerebral
Bisphosphoglycerate Mutase Deficiency Protects against Cerebral Malaria and Severe Malaria-Induced Anemia.
Malaria, Falciparum
The use of enzymopathic human red cells in the study of malarial parasite glucose metabolism.
Neoplasms
Phosphoglycerate mutase, 2,3-bisphosphoglycerate phosphatase and enolase activity and isoenzymes in lung, colon and liver carcinomas.
Polycythemia
Congenital and acquired polycythemias.
Erythrocytosis due to bisphosphoglycerate mutase deficiency with concurrent glucose-6-phosphate dehydrogenase (G-6-PD) deficiency.
Hemolytic anemias and erythrocyte enzymopathies.
Uniparental disomy (UPD) of a novel bisphosphoglycerate mutase (BPGM) mutation leading to erythrocytosis.
[Diphosphoglyceromutase deficiency: new cases associated with erythrocytosis]